Butler Hospital

Open enrollment across a mixed-phase pipeline

According to ClinicalTrials.gov-derived indexes, Butler Hospital sits in the top decile of US sponsors by registered trial count (#237 of 15,742 sponsors by registered trial count).

103 total trials 9 currently recruiting 85 completed top decile by trial count

Butler Hospital: 103 sponsored US clinical trials, 9 recruiting.

Butler Hospital sponsors 103 registered US clinical trials on ClinicalTrials.gov, 9 of them currently recruiting, and 85 completed. 17 of these trials are in Phase 3-4 (later-stage) and 14 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Depression, with 5 trials.

Top-decile sponsor footprint

Butler Hospital ranks in the top decile of sponsors by registered trial count (#237 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.

Trial completion reliability score

B 84/100

85 of 87 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (97.7%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.

Open and recent trials

103 total, page 1 of 3

RECRUITING NA

Teenthrive 2: Treatments for Improving Mood in Teens

NCT07475845

RECRUITING NA

Video Intervention for Older Adults With Chronic Pain

NCT07404618

RECRUITING NA

Women's Wellbeing Study

NCT07195019

RECRUITING NA

Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial (2)

NCT05180344

RECRUITING NA

tDCS to Decrease Opioid Relapse (UH3)

NCT06432465

RECRUITING NA

Optimization of a Behavioral Intervention to Increase Physical Activity in Older Adults Living With HIV

NCT05752500

RECRUITING NA

Mood and Thought Process Study

NCT05585775

RECRUITING Phase 1

Repurposing Nucleoside Reverse Transcriptase Inhibitors for Treatment of AD

NCT04500847

RECRUITING NA

Testing a Lifestyle Physical Activity Intervention for Women With Depression in Alcohol Treatment

NCT04667520

ACTIVE NOT RECRUITING NA

Exercise to Augment TMS in Those With Treatment Resistant Depression

NCT05913401

ACTIVE NOT RECRUITING NA

Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use - RCT

NCT06239701

ACTIVE NOT RECRUITING NA

EMA-Guided Maintenance TMS for Depression

NCT06145594

ACTIVE NOT RECRUITING NA

EMA/EMI for Psychiatrically Hospitalized Emerging Adults Who Drink to Cope

NCT05074030

ACTIVE NOT RECRUITING Phase 4

Methadone-Maintained Smokers Switching to E-Cigarettes

NCT05206435

ACTIVE NOT RECRUITING

EEG Biomarker Study for Participants in the Neurolief "MOOD" Trial

NCT05178784

ACTIVE NOT RECRUITING Phase 4

Effectiveness of Deep Brain Stimulation for Treating People With Treatment Resistant Obsessive-Compulsive Disorder

NCT00640133

COMPLETED NA

Treatments for Improving Mood in Women Survivors of Interpersonal Violence: A Community-Engaged Study-1.2

NCT06657950

COMPLETED NA

Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Randomized Trial

NCT05202756

COMPLETED NA

Cranial Electrotherapy Stimulation: Piloting a Road to PTSD Prevention in First Responders

NCT06203717

COMPLETED NA

Feasibility, Acceptability, and Preliminary Efficacy of a Novel Personalized Mobile Intervention for Suicide - Open Trial

NCT05180331

COMPLETED NA

Examining Feasibility, Acceptability, and Sustainability of a Novel Personalized Smartphone Intervention for Suicide - Open Trial

NCT05180383

COMPLETED NA

Suicide Prevention for Justice Involved Managed Care Subscribers

NCT05579600

COMPLETED NA

Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase II

NCT04641221

COMPLETED NA

Development of a Lifestyle Physical Activity Intervention to Reduce Risk for Perinatal Cannabis Use

NCT05528380

COMPLETED NA

Pilot RCT of a Video-based Intervention for Suicide Prevention

NCT05127330

COMPLETED NA

Development of a Video-based Intervention for Suicide Prevention

NCT04307394

COMPLETED NA

Optimization and Multi-Site Feasibility of Yoga for Chronic Pain in People in YOGAMAT-II - Phase I

NCT04646148

COMPLETED NA

Suicide Prevention Intervention for Schizophrenia-Spectrum Disorders

NCT04221269

COMPLETED NA

Intervention for Comorbid Substance Use and Bipolar Disorders

NCT04202393

COMPLETED Early Phase 1

Effects of L-theanine on Motor Cortex Excitability in Healthy Subjects: A Paired-Pulse TMS Study

NCT04749745

COMPLETED NA

Effect of tDCS Timing on Safety Memory in PTSD

NCT04152772

COMPLETED NA

Modulating Prefrontal Circuits Underlying Behavioral Flexibility in OCD: A TMS Study

NCT04165577

COMPLETED NA

Inhibitory Control: Effects of Modulation

NCT04247334

COMPLETED NA

tDCS to Decrease Opioid Relapse (UG3)

NCT03842137

COMPLETED NA

Mobile After-Care Support App: Pilot RCT

NCT03955250

COMPLETED NA

Mobile After-Care Intervention to Support Post-Hospital Transition (MACS)

NCT03769493

COMPLETED NA

A Targeted, Real-Time, Technology-Supported Intervention for Patients With Alcohol Use Disorder on Disulfiram

NCT03543735

COMPLETED NA

The Development of a Personalized, Real-time Intervention

NCT03518619

COMPLETED NA

A Machine Learning Approach for Inferring Alcohol Intoxication Levels From Gait Data

NCT03246490

COMPLETED NA

Storytelling Video Intervention for Depressed Primary Care Patients - Pilot Trial

NCT02311725

COMPLETED NA

Study of Yoga vs. Health Education for Chronic Pain in Persons Receiving Opioid Agonist Therapy

NCT03022890

COMPLETED NA

tDCS for Increasing Exercise Adherence in Depressed Individuals

NCT03178903

COMPLETED NA

Treating Comorbid Pain and Depression in HIV+ Individuals

NCT02766751

COMPLETED NA

A Tailored Physical Activity Smartphone App for Patients With Alcohol Dependence

NCT02958280

COMPLETED NA

Transforming Recovery Through Exercise and Community

NCT03065049

COMPLETED NA

Storytelling Video Intervention for Depressed Primary Care Patients - Open Trial

NCT02309060

COMPLETED Phase 3

Neuroimaging Predictors of Relapse During Treatment for Opiate Dependence

NCT02696096

TERMINATED Phase 2

NeoSync TMS Treatment for Bipolar I Depression

NCT02839798

COMPLETED NA

An App to Aid in Transitioning Off Opioid Medication

NCT03077932

COMPLETED NA

Wellness for 2: Understanding How to Foster Well Being for Mom and Her Baby

NCT02738216

Page 1 of 3 Next →

Phase Distribution

PhaseTrial count
Phase 1 6
Phase 2 8
Phase 3 13
Phase 4 4

What is open in the Butler Hospital pipeline

9 recruiting of 103 indexed (9% open); 85 completed (83%).

Phase mix: 17 late (III/IV) vs 14 early (I/II) (balanced across stages).

Top condition: Depression (5 trials), 9 others listed.

How open-pipeline share is computed

Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.

Butler Hospital: open-pipeline peers nationwide

Peers matched on 103 registered trials and 9% open enrollment, not the therapeutic-area sidebar.

Butler Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 020406080100120 0%10%20%30%40% Total trials Recruiting share Butler HospitalBoston University Charles River CampusKessler FoundationVirginia Polytechnic Institute and State UniversityJohnson & Johnson Pharmaceutical Research & Development, L.L.C.AMAG PharmaceuticalsIowa State UniversityNew Approaches to Neuroblastoma Therapy ConsortiumRhythm Pharmaceuticals
Butler Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

Butler Hospital sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 103 trials (± recruiting share)

Sponsors near 9% open enrollment (± trial volume)

What to do with this Butler Hospital page

103 registered trials is a research-attention snapshot, not an endorsement of Butler Hospital or any single study.

  • 9 of Butler Hospital's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
  • Depression is the condition Butler Hospital studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Depression trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Butler Hospital pipeline card: 103 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.